- •
Acquired head and neck vascular tumors are rare and account for less than 5% of head and neck neoplasms.
- •
Management of head and neck paragangliomas has evolved from primarily surgical to more conservative treatment consisting of observation and nonsurgical therapy.
- •
The mainstay treatment of juvenile nasopharyngeal angiofibroma and hemangiopericytoma is surgery, with radiation reserved for adjuvant therapy and recurrent tumors.
Acquired Vascular Tumors of the Head and Neck
Section snippets
Key points
Natural History and Physical Findings
Paragangliomas are vascular neoplasms that arise from the extraadrenal paraganglia derived from the neural crest and most commonly occur in the head and neck region. These tumors are closely associated with either blood vessels (carotid artery, jugular bulb) or nerves (vagus, tympanic plexus). Paragangliomas are usually slow-growing tumors with an average growth rate of 1 to 2 mm per year and a median doubling time of 4.2 years. Their growth pattern may be described as biphasic because very
Natural History and Physical Findings
Juvenile nasopharyngeal angiofibroma (JNA) is a highly vascular, histologically benign but locally aggressive and destructive tumor that exclusively affects adolescent boys. It accounts for approximately 0.5% of all head and neck neoplasms.57, 58 The etiologic factors and pathogenesis of the disease remain to be elucidated. The tumor seems to originate in the posterior nasal cavity instead of the nasopharynx, specifically in the posterolateral wall of the superior aspect of the nasal cavity, at
Treatment
The mainstay treatment of JNA is surgery, especially for the early-stage disease process. Previously, the various surgical approaches were: transpalatal, transnasal, transantral, transmandibular, transzygomatic, combined craniotomy and rhinotomy, lateral rhinotomy, and midface degloving. With increasing experience using endoscopic nasal techniques, excellent results have been achieved with this more minimally invasive approach. Ultimately, the approach chosen is determined by tumor location,
Natural History and Physical Findings
Hemangiopericytoma of the head and neck is a rare neoplasm that originates from the pericytes or cells of Zimmerman surrounding normal vascular channels.87 It is considered by some to be a lesion with low risk of malignant potential and by others a malignant lesion of high metastatic potential.87, 88 Thus, it is known as a tumor that varies greatly in appearance and biologic behavior.89 Hemangiopericytomas represent 3% to 5% of all soft-tissue sarcomas90 and 1% of all vascular tumors.91
References (113)
- et al.
Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory
Lancet
(1989) - et al.
Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases
Am J Surg
(1971) - et al.
Diagnosis and management of paragangliomas of the skull base
Am J Surg
(1990) - et al.
The temporal bone. Contemporary diagnostic dilemmas
Radiol Clin North Am
(1998) - et al.
Carotid body tumors, inheritance, and a high incidence of associated cervical paragangliomas
Am J Surg
(1996) - et al.
Optimum dose of radiotherapy for chemodectomas of the middle ear
Int J Radiat Oncol Biol Phys
(1980) - et al.
Radiotherapy for head and neck paragangliomas
Oper Tech Otolaryngol
(2016) - et al.
Anterior approaches in juvenile nasopharyngeal angiofibromas with intracranial extension
Otolaryngol Head Neck Surg
(2000) - et al.
Endoscopic-assisted midfacial degloving approach for type III juvenile angiofibroma
Int J Pediatr Otorhinolaryngol
(2004) - et al.
Application of cyberknife for the treatment of juvenile nasopharyngeal angiofibroma: a case report
Auris Nasus Larynx
(2002)
Endoscopic resection of a recurrent sinonasal hemangiopericytoma
Am J Otolaryngol
Hemangiopericytoma. Literature review and clinical presentations
Am J Surg
Distinctive soft tissue tumors of the head and neck
Mod Pathol
Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal
Cancer
Diagnosis and management of catecholamine secreting glomus tumors
Laryngoscope
The paraganglionic chemorector system
The glomus tumor and its biology
Laryngoscope
Familial carotid body tumors: case report and epidemiologic review
Cancer
Carotid body tumors: a review of 30 patients with 46 tumors
Laryngoscope
First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas)
J Med Genet
Proportion of heritable paraganglioma cases and associated clinical characteristics
Laryngoscope
Glomus bodies and tumors
N Y State J Med
Vagal paraganglioma: a review of 46 patients treated during a 20-year period
Arch Otolaryngol Head Neck Surg
Laryngeal paraganglioma in a five-year-old child–the youngest case ever recorded
J Laryngol Otol
Malignant glomus tumors
Laryngoscope
Carotid body tumors: a review
J Otolaryngol
Carotid body tumor
Arch Surg
Carotid body tumours. A review of 52 cases
S Afr Med J
Carotid body tumour: 30 years experience
Br J Surg
High-resolution CT investigation of nonchromaffin paragangliomas of the temporal bone
AJNR Am J Neuroradiol
Paragangliomas of the neck
Arch Surg
A comprehensive study of tumors of the glomus jugulare
Laryngoscope
Neurotologic skull base surgery for glomus tumors. Diagnosis for treatment planning and treatment options
Laryngoscope
Combined endovascular and surgical treatment of head and neck paragangliomas–a team approach
Head Neck
Part III pathology of head and neck cancer
Glomus jugulare and vagale
Ann Otol Rhinol Laryngol
Skull base surgery for glomus jugulare tumors
Am J Otol
Tumors of the extra-adrenal paraganglion system (including chemorecetors)
Glomus vagale tumors
Ann Otol Rhinol Laryngol
Glomus vagale: paraganglioma of the vagus nerve
Laryngoscope
Vagal body tumors: diagnosis and treatment
Laryngoscope
Paraganglioma of the orbit with extension to the middle cranial fossa: case report
Neurosurgery
Imaging of pheochromocytoma and paraganglioma
Fam Cancer
Natural history of cervical paragangliomas: outcomes of observation of 43 patients
Arch Otolaryngol Head Neck Surg
Natural history of glomus jugulare: a review of 16 tumors managed with primary observation
Otolaryngol Head Neck Surg
Head and neck paragangliomas: an update on evaluation and management
Otolaryngol Head Neck Surg
Effects of preoperative embolization on glomus jugulare tumors
Laryngoscope
A multidisciplinary approach to reducing morbidity and operative blood loss during resection of carotid body tumor
Surg Gynecol Obstet
Diagnostic and therapeutic approaches to carotid body tumors. Review of 24 patients
Arch Surg
Cited by (16)
Pediatric Neck Masses: Imaging Guidelines and Recommendations
2022, Radiologic Clinics of North AmericaCitation Excerpt :There is also an association with syndromes such as multiple endocrine neoplasia and von Hippel–Lindau disease. Depending on the histology, nuclear medicine diagnosis and therapy can be performed using various radiolabeled somatostatin receptor analogs, including octreotide, meta-iodobenzylguanidine, fluorodeoxyglucose, fluorodopa, and DOTA-conjugated peptides52–55 (Fig. 11). Sarcomas are heterogeneous malignancies of mesenchymal origin, which can arise from soft tissue or bone.
Jugular paraganglioma presenting as Tapia syndrome
2020, NeurologiaSurgical Management of Bilateral Carotid Body Tumors
2019, Annals of Vascular SurgeryCitation Excerpt :These neoplasms are paragangliomas, which is a type of tumor that originates from neural crest cells.1 CBTs are the most common type of head and neck paragangliomas followed by jugular foramen and vagal tumors being usually benign with slow-growing and highly vascularized masses that are in close relation with the carotid vessels.1,2 These neoplasms are generally asymptomatic and as they are uncommon entities, it is often difficult for primary care physicians to suspect and timely establish the diagnosis often mistaking these masses with an enlarged lymph node or thyroid gland.
A dosimetric comparison of proton versus photon irradiation for paediatric glomus tumour: a case study
2023, Journal of Radiotherapy in PracticeIntegrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors
2024, Current Oncology ReportsMRI features of sinonasal tract angiofibroma/juvenile nasopharyngeal angiofibroma: Case series and systematic review
2023, Journal of Neuroimaging
Disclosure: The authors have nothing to disclose.